Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
Blood-based Mass Spectrometry MRD Testing for Myeloma : EasyM | EHA 2026
HealthTreeDescription
Can a simple blood test replace bone marrow biopsies for MRD testing in multiple myeloma? At EHA 2026, researchers presented exciting data on EasyM, a blood-based mass spectrometry assay designed to detect measurable residual disease (MRD) with remarkable sensitivity.
In this video, we explore how EasyM uses advanced mass spectrometry technology to track myeloma proteins in the blood, potentially offering a less invasive way to monitor disease response, assess treatment effectiveness, and detect relapse earlier.
If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/628617/src=htu
For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!
Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.